Related Experiment Video
Updated: Apr 30, 2026

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
Published on: July 18, 2019
Single-cell eQTL analysis identifies genetic variation underlying metabolic dysfunction-associated steatohepatitis.
Sung Eun Hong1, Seon Ju Mun2, Young Joo Lee3
1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Single-cell eQTL analysis reveals genetic drivers of Metabolic dysfunction-associated steatotic liver disease (MASLD). This study identifies key gene-regulatory networks influencing MASLD risk and offers insights for personalized therapies.
Area of Science:
- Genomics
- Hepatology
- Systems Biology
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) presents significant medical and socioeconomic challenges.
- Understanding the genetic underpinnings of MASLD is crucial for developing targeted therapies.
Purpose of the Study:
- To identify genetic variations influencing gene expression in MASLD using single-cell expression quantitative trait locus (sc-eQTL) analysis.
- To uncover cell-state-specific gene regulation and its contribution to MASLD heritability.
Main Methods:
- Performed sc-eQTL analysis on liver biopsies from patients with MASLD and healthy controls.
- Integrated transcription factor data to identify functional regulatory units (quartets).
- Analyzed genotype-specific regulation of gene expression in relation to MASLD risk.
Main Results:
- Identified over 3,500 sc-eQTLs across major liver cell types and cell-state-interacting eQTLs (ieQTLs).
- Demonstrated significant enrichment of ieQTLs for MASLD heritability (odds ratio 10.27).
- Discovered a functional quartet involving EFHD1, FOXO1, hepatocyte maladaptation, and MASLD risk.
Conclusions:
- sc-eQTL analysis is a powerful approach to dissecting genetic contributions to complex liver diseases like MASLD.
- Identified specific genetic regulatory mechanisms, such as FOXO1's role in EFHD1 regulation, contributing to MASLD.
- Findings pave the way for genotype-informed, personalized therapeutic strategies for MASLD.
More Related Videos
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024